Elma Feric Bojic
About Elma Feric Bojic
Elma Feric Bojic is a Senior Scientist II in Translational Medicine with extensive experience in neuroscience and bioengineering. She has held positions at various pharmaceutical companies and has a strong academic background, including a PhD in Genetics and Bioengineering.
Current Role at Deciphera Pharmaceuticals
Elma Feric Bojic serves as a Senior Scientist II in Translational Medicine at Deciphera Pharmaceuticals. She has been in this role since 2023. In her position, she contributes to the development of biomarker strategies in oncology, leveraging her extensive background in both neuroscience and bioengineering.
Previous Experience in Translational Medicine
Before her current role, Elma worked at Fulcrum Therapeutics as a Senior Scientist in Translational Medicine from 2021 to 2022. She also held a position as a Senior Scientist in Translational Medicine at Deciphera Pharmaceuticals for nine months in 2022. Additionally, she was a Scientist II at Ohana Biosciences, Inc. from 2019 to 2021, and an Associate Scientist at Amgen from 2008 to 2014.
Educational Background in Biotechnology and Neuroscience
Elma holds a PhD in Genetics and Bioengineering from International Burch University, completed between 2014 and 2017. She also earned an MS in Biotechnology and Neuroscience from Harvard University in 2013. Elma is currently pursuing an MBA at the Questrom School of Business, Boston University, from 2022 to 2024.
Work Experience at Massachusetts General Hospital
Elma worked as a Staff Scientist at Massachusetts General Hospital from 2005 to 2008. This role contributed to her foundational experience in the field, enhancing her expertise in translational medicine and research methodologies.
Study Abroad Experience
In 2016, Elma participated in a study abroad program at The Julius Maximilians University of Würzburg for 11 months. This experience expanded her academic and cultural perspectives, contributing to her professional development.